V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006895 | 220002663 | 0 | 69 | Palliative (P) | 2015-10-17 | 2015-10-31 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220031259 | CARBOPLATIN + PACLITAXEL |
| 220006898 | 220002664 | 1.56 | null | Palliative (P) | 2013-11-29 | 2013-12-06 | Dasatinib | 02 | N | 220031267 | DASATINIB |
| 220006899 | 220002665 | null | 155 | Palliative (P) | 2016-09-03 | 2016-09-09 | AML16 DA 3+10 | N | N | 220031271 | AML16 TRIAL |
| 220006900 | 220002665 | 1.64 | 52.1 | Curative (C) | 2013-09-17 | 2013-10-23 | AML16 DA 3+8 | N | N | 220031271 | AML16 TRIAL |
| 220006902 | 220002667 | 1.73 | 76.2 | Palliative (P) | 2014-04-17 | 2014-04-23 | Dasatinib | 99 | N | 220031275 | DASATINIB |
| 220006904 | 220011540 | 1.76 | 76.4 | Disease modification (D) | 2017-03-08 | 2017-03-09 | IDARUBICIN + TRETINOIN | 2 | N | 220031277 | IDARUBICIN + TRETINOIN |
| 220006905 | 220002669 | 1.8 | 84.2 | Palliative (P) | 2015-03-24 | 2015-03-24 | GemCarbo Days 1+8 | N | N | 220031278 | GEMCARBO |
| 220006906 | 220002670 | 1.59 | 74.8 | Curative (C) | 2014-09-07 | 2014-09-07 | AML18 PILOT TRIAL | Y | N | 220031279 | PILOT TRIAL |
| 220006907 | 220011541 | 1.69 | 71 | Palliative (P) | 2017-10-12 | 2017-10-23 | GemCarbo Days 1+8 | N | N | 220031282 | GEMCARBO |
| 220006908 | 220002671 | 1.65 | 59.7 | Palliative (P) | 2016-04-16 | 2016-04-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220031284 | CISPLATIN + GEMCITABINE |
| 220006909 | 220002672 | 1.79 | 108.8 | Palliative (P) | 2013-09-08 | 2013-10-06 | GemCarbo Days 1+8 | N | N | 220031285 | GEMCARBO |
| 220006910 | 220002672 | 0 | 83.1 | Palliative (P) | 2013-12-31 | 2014-01-02 | CARBOPLATIN + PACLITAXEL | null | N | 220031285 | CARBOPLATIN + PACLITAXEL |
| 220006911 | 220002672 | 1.61 | 48.7 | Palliative (P) | 2015-04-20 | 2015-04-26 | CARBOPLATIN + PACLITAXEL | 2 | N | 220031285 | CARBOPLATIN + PACLITAXEL |
| 220006912 | 220002672 | 1.75 | 54 | Palliative (P) | null | 2016-05-30 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 220031285 | CISPLATIN + GEMCITABINE |
| 220006913 | 220002673 | 1.65 | 66 | Palliative (P) | 2017-02-12 | 2017-02-19 | AML16 DA 3+10 | N | N | 220031298 | AML16 TRIAL |
| 220006914 | 220011543 | 1.63 | 71 | Palliative (P) | 2015-06-21 | 2015-06-21 | GemCarbo Days 1+8 | 2 | N | 220031299 | GEMCARBO |
| 220006915 | 220011543 | null | 54 | Palliative (P) | 2016-04-08 | 2016-04-25 | IDARUBICIN + TRETINOIN | N | N | 220031299 | IDARUBICIN + TRETINOIN |
| 220006916 | 220002674 | 1.79 | 87 | Curative (C) | 2013-12-20 | 2013-12-31 | AML16 DA 3+8 | Y | N | 220031302 | AML16 TRIAL |
| 220006917 | 220002675 | 1.66 | 125 | Curative (C) | null | 2013-06-22 | AML 18 TRIAL | N | N | 220031303 | AML18 TRIAL |
| 220006918 | 220002676 | 1.72 | 106 | Palliative (P) | 2017-12-11 | 2017-12-29 | CISPLATIN + GEMCITABINE | N | N | 220031305 | CISPLATIN + GEMCITABINE |
| 220006919 | 220002677 | 1.69 | 48.1 | Curative (C) | null | 2017-05-17 | AML 18 TRIAL | 01 | Y | 220031306 | AML18 TRIAL |
| 220006920 | 220002678 | null | 63.8 | Palliative (P) | 2014-07-17 | 2014-08-02 | GemCarbo Days 1+8 | N | N | 220031309 | GEMCARBO |
| 220006921 | 220002679 | null | 72.5 | Palliative (P) | 2014-05-09 | 2014-06-17 | AML16 Low Dose Cytarabine | Y | N | 220031310 | AML16 TRIAL |
| 220006922 | 220002680 | 1.63 | 63.4 | Curative (C) | 2017-12-05 | 2017-12-06 | AML18 PILOT TRIAL | 01 | N | 220031314 | PILOT TRIAL |
| 220006923 | 220002681 | 1.62 | 83 | Palliative (P) | 2017-02-08 | 2017-02-14 | AML16 Low Dose Cytarabine | N | N | 220031317 | AML16 TRIAL |
| 220006924 | 220002682 | 1.64 | 124 | Disease modification (D) | 2016-06-24 | 2016-06-29 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220031320 | IDARUBICIN + TRETINOIN |
| 220006925 | 220002682 | 1.67 | 58.7 | Palliative (P) | 2018-10-15 | 2018-10-28 | Dasatinib | 2 | N | 220031320 | DASATINIB |
| 220006926 | 220002683 | null | 63.4 | null | null | 2013-09-10 | Dasatinib | N | N | 220031329 | DASATINIB |
| 220006927 | 220002684 | 0 | 51.5 | Palliative (P) | null | 2017-09-27 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220031330 | CISPLATIN + GEMCITABINE |
| 220006928 | 220002685 | 1.62 | 59.7 | Curative (C) | 2017-08-09 | 2017-08-31 | IDARUBICIN + TRETINOIN | N | N | 220031331 | IDARUBICIN + TRETINOIN |
| 220006929 | 220002686 | null | 55.5 | Curative (C) | 2015-03-30 | 2015-04-04 | AML18 PILOT TRIAL | Y | N | 220031332 | PILOT TRIAL |
| 220006930 | 220002686 | 1.64 | null | Palliative (P) | 2014-06-25 | 2014-06-25 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220031332 | CISPLATIN + GEMCITABINE |
| 220006931 | 220002686 | 1.78 | 78.55 | Curative (C) | null | 2017-05-29 | AML 18 TRIAL | Y | N | 220031332 | AML18 TRIAL |
| 220006932 | 220002686 | null | 78.1 | Curative (C) | 2015-09-12 | 2015-09-19 | AML18 PILOT TRIAL | Y | N | 220031332 | PILOT TRIAL |
| 220006933 | 220002687 | 0 | null | Curative (C) | 2017-10-21 | 2017-10-21 | AML 18 Pilot Trial | 01 | N | 220031338 | PILOT TRIAL |
| 220006934 | 220002688 | 0 | 64.3 | Palliative (P) | 2016-11-06 | 2016-11-11 | Dasatinib | 02 | N | 220031339 | DASATINIB |
| 220006935 | 220002689 | null | 77.1 | Palliative (P) | 2017-09-09 | 2017-09-16 | Dasatinib | N | N | 220031340 | DASATINIB |
| 220006936 | 220002690 | 1.82 | 92.8 | Palliative (P) | 2014-07-17 | 2014-07-18 | Idarubicin+Tretinoin Spanish Crse4 | null | N | 220031342 | IDARUBICIN + TRETINOIN |
| 220006937 | 220011546 | 1.65 | 45.8 | Palliative (P) | 2018-02-25 | 2018-03-03 | Dasatinib | 2 | N | 220031343 | DASATINIB |
| 220006938 | 220002691 | null | 113 | Palliative (P) | 2014-04-25 | 2014-04-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220031344 | CARBOPLATIN + PACLITAXEL |
| 220006939 | 220002692 | 1.73 | 0 | Adjuvant (A) | 2016-02-20 | 2016-02-27 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 220031346 | CISPLATIN + GEMCITABINE |
| 220006940 | 220002693 | null | 108 | Palliative (P) | 2015-06-20 | 2015-06-26 | Dasatinib | 2 | N | 220031347 | DASATINIB |
| 220006941 | 220002693 | 1.85 | 64.5 | Palliative (P) | 2013-09-19 | 2013-09-24 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031347 | CARBOPLATIN + PACLITAXEL |
| 220006942 | 220002694 | 1.82 | 67 | Curative (C) | 2016-02-20 | 2016-02-25 | AML16 DA 3+10 | Y | N | 220031352 | AML16 TRIAL |
| 220006943 | 220002695 | 0 | 60.3 | Disease modification (D) | null | 2016-04-27 | AML16 DA 3+10 | N | N | 220031353 | AML16 TRIAL |
| 220006944 | 220002695 | 1.67 | 95 | Curative (C) | 2013-05-10 | 2013-06-13 | AML16 DA 3+10 | N | N | 220031353 | AML16 TRIAL |
| 220006945 | 220002696 | null | null | Palliative (P) | 2015-01-25 | 2015-02-18 | GemCarbo Days 1+8 | N | N | 220031357 | GEMCARBO |
| 220006946 | 220002697 | 1.6 | 61 | Curative (C) | 2014-01-07 | 2014-02-15 | AML16 DA 3+10 | N | N | 220031359 | AML16 TRIAL |
| 220006947 | 220011549 | 1.68 | 45 | Neo-adjuvant (N) | 2014-04-10 | 2014-04-12 | IDARUBICIN + TRETINOIN | N | N | 220031362 | IDARUBICIN + TRETINOIN |
| 220006948 | 220011549 | 1.65 | null | Curative (C) | 2014-10-22 | 2014-10-22 | IDARUBICIN + TRETINOIN | N | N | 220031362 | IDARUBICIN + TRETINOIN |